Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 73,662 | 65,524 | 23,795 | 31,622 | 22,429 |
| Cost of Goods | 2,666 | 3,049 | 3,228 | 3,086 | 3,367 |
| Gross Profit | 70,996 | 62,475 | 20,567 | 28,536 | 19,062 |
| Operating Expenses | 231,561 | 229,158 | 220,383 | 198,195 | 179,711 |
| Operating Income | -159,899 | -166,634 | -199,588 | -169,573 | -160,282 |
| Interest Expense | 12,001 | 7,686 | 3,951 | 3,683 | 3,955 |
| Other Income | -4,196 | -6,072 | -5,418 | -26,750 | -1,034 |
| Pre-tax Income | -176,096 | -180,392 | -208,957 | -200,006 | -165,271 |
| Net Income Continuous | -176,096 | -180,392 | -208,957 | -200,006 | -165,271 |
| Net Income | $-176,096 | $-180,392 | $-208,957 | $-200,006 | $-165,271 |
| EPS Basic Total Ops | -0.87 | -0.90 | -1.04 | -1.00 | -0.83 |
| EPS Basic Continuous Ops | -0.87 | -0.90 | -1.04 | -1.00 | -0.83 |
| EPS Diluted Total Ops | -0.87 | -0.90 | -1.04 | -1.00 | -0.83 |
| EPS Diluted Continuous Ops | -0.87 | -0.90 | -1.04 | -1.00 | -0.83 |
| EBITDA(a) | $-151,041 | $-158,429 | $-192,830 | $-161,661 | $-152,698 |